A bladder cancer patient-derived xenograft displays aggressive growth dynamics in vivo and in organoid culture
Open Access
- 25 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 11 (1), 1-11
- https://doi.org/10.1038/s41598-021-83662-7
Abstract
Bladder cancer is among the most prevalent cancers worldwide. Currently, few bladder cancer models have undergone thorough characterization to assess their fidelity to patient tumors, especially upon propagation in the laboratory. Here, we establish and molecularly characterize CoCaB 1, an aggressive cisplatin-resistant muscle-invasive bladder cancer patient-derived xenograft (PDX) and companion organoid system. CoCaB 1 was a subcutaneous PDX model reliably transplanted in vivo and demonstrated an acceleration in growth upon serial transplantation, which was reflected in organoid and 2D cell culture systems. Transcriptome analysis revealed progression towards an increasingly proliferative and stem-like expression profile. Gene expression differences between organoid and PDX models reflected expected differences in cellular composition, with organoids enriched in lipid biosynthesis and metabolism genes and deprived of extracellular components observed in PDXs. Both PDX and organoid models maintained the histological fidelity and mutational heterogeneity of their parental tumor. This study establishes the CoCaB 1 PDX and organoid system as companion representative tumor models for the development of novel bladder cancer therapies.Funding Information
- Howard J. Cohen Bladder Cancer Foundation
- Seattle Translational Tumor Research
- National Institute of Health (R37 CA230617)
- Burroughs Wellcome Fund (1012314.02)
- Emerson Collective (691630)
- Robert J. Kleberg Jr. and Helen C. Kleberg Foundation
- National Institutes of Health (P30 CA015704)
- U.S. Department of Defense (W81XWH-19-1-0624)
This publication has 48 references indexed in Scilit:
- Phenotypic and Transcriptional Fidelity of Patient-Derived Colon Cancer Xenografts in Immune-Deficient MicePLOS ONE, 2013
- TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusionsGenome Biology, 2013
- A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder CancerEuropean Urology, 2012
- Integrative Genomics Viewer (IGV): high-performance genomics data visualization and explorationBriefings in Bioinformatics, 2012
- p300 mediates cellular resistance to doxorubicin in bladder cancerMolecular Medicine Reports, 2011
- Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapseThe Journal of Experimental Medicine, 2011
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- FoxO3 Regulates Neural Stem Cell HomeostasisCell Stem Cell, 2009
- Wnt7a Activates the Planar Cell Polarity Pathway to Drive the Symmetric Expansion of Satellite Stem CellsCell Stem Cell, 2009
- BRAF mutation predicts sensitivity to MEK inhibitionNature, 2005